toxylact: a05ba07 tidiacid arginine

The first professional lActological database in the word

ATC class A05BA07 comprises tidiacic arginine, a hepatoprotective liver therapy agent combining tidiacic and L‑arginine, used for toxic liver damage and metabolic support of hepatocytes.medpedia.framar+5

Pharmacological profile

Tidiacic arginine (Tiadilon) is a 1:1 salt of tidiacic (thiazolidine‑2,4‑dicarboxylic acid) and the amino acid L‑arginine. Tidiacic acts as an antioxidant and sulfur donor, supporting hepatic detoxification and protecting hepatocytes from toxic injury. The L‑arginine component contributes to nitrogen metabolism and nitric‑oxide–mediated microcirculatory effects, which may improve hepatic blood flow and cellular function. In the WHO ATC classification, tidiacic arginine is coded A05BA07 within A05B “liver therapy, lipotropics,” indicating use as a supportive liver therapy rather than a primary disease‑modifying agent.wikipedia+6

Indications and clinical use

National references describe tidiacic arginine as a hepatoprotective drug indicated in toxic liver damage and other conditions where enhancement of hepatic detoxification is desired. It is used as adjunctive therapy in acute or chronic hepatic impairment of toxic, metabolic or drug‑induced origin, always within a broader etiological and symptomatic treatment strategy. The product is generally positioned as liver therapy for bile and liver disorders, not as specific antiviral or antifibrotic treatment.pubchem.ncbi.nlm.nih+4

Dosage, administration and contraindications

Local prescribing information emphasizes that the dose regimen must be individualized and determined by a physician, particularly in patients with complex hepatic disease and comorbidities. Oral formulations are most common; parenteral preparations may exist depending on the national market and regulatory status. Hypersensitivity to tidiacic, arginine or any excipient constitutes a formal contraindication and requires avoidance of the drug. As a supportive therapy, tidiacic arginine should be integrated cautiously with other hepatically‑metabolized drugs to minimize cumulative metabolic burden.drugbank+3

Toxicological considerations

Tidiacic, as a sulfur‑donor antioxidant, is intended to mitigate hepatotoxicity rather than induce it, and it has been used in toxic liver damage in clinical practice. However, systematic toxicology data for tidiacic arginine in humans are limited, and the compound is generally classified as a small‑molecule liver therapy with unknown maximum clinical development phase in some databases. L‑arginine itself has a broad safety record, but high doses can alter hemodynamics, urea cycle flux and electrolyte balance, which is relevant in advanced liver disease. Overall toxicological risk assessment should consider the underlying hepatic pathology, concomitant medications and the patient’s metabolic reserve, with close monitoring of liver function tests and clinical status.ebi+8

Lactation and pregnancy safety

There are no dedicated human studies evaluating tidiacic arginine use during pregnancy or breastfeeding, and specific product information typically omits detailed reproductive safety data. L‑arginine alone has been studied in pregnancy, where supplementation improved outcomes in hypertensive disorders and fetal growth, with an acceptable maternal–neonatal safety profile when used under controlled conditions. Animal and livestock studies show that arginine supplementation during lactation can beneficially modulate milk composition, offspring growth and gut microbiota, supporting its physiological role in perinatal nutrition, but these data are not specific to tidiacic arginine medicinal products. In the absence of direct clinical data for tidiacic arginine, use during pregnancy and lactation should be avoided unless the potential benefit clearly outweighs unknown risks, and decisions must be individualized with specialist consultation.pubmed.ncbi.nlm.nih+9

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.